JUN 23, 2020 9:00 AM PDT

Fast, Cost-effective and High-throughput Solutions for DNA Assembly

Speakers

Abstract

DATE:  June 23, 2020

TIME:   9:00am PDT

 

In the last eight years the field of Synthetic Biology has erupted into a massive industry driving innovation in multiple disciplines, from sustainable materials to agricultural sciences. High-throughput automation is key to successful implementation of synthetic biology approaches in all disciplines. Supporting the Build segment of the Design-Build-Test cycle, the “tipless” Echo acoustic liquid handling technology from Beckman Coulter Life Sciences enables setup of DNA assembly reactions in a fraction of the time compared to tip-based liquid handlers.
 
The Echo 525 Liquid Handler can transfer down to 25 nL with high accuracy and precision. Automated SynBio workflows can be performed on the Echo in a fraction of standard reaction volumes, reducing reagent use and resulting in cost savings. Whether building DNA constructs with Gibson, Golden Gate or other assembly methods, contactless acoustic Echo liquid handlers create a high-throughput, fully automated system for pooling oligos, assembling DNA fragments and spotting colonies.
Key to successful, highly automated DNA assembly workflows is reliable, high-quality input material.  Beckman Coulter Life Sciences sister company Integrated DNA Technologies (IDT) is a major solution provider in Synthetic Biology. For more than 30 years IDT has developed innovative solutions for genomics and molecular biology research applications. In 2012, IDT launched gBlocks™ Gene Fragments, which quickly became the preferred double-stranded DNA fragment solution for gene and pathway assembly. IDT will be announcing the addition of an exciting new product to their gene fragment portfolio that will further enable successful high-throughput assembly and cloning of long DNA constructs.
Learn how the Echo 525 Liquid Handler from Beckman Coulter Life Sciences, coupled with the latest synthetic biology products from IDT, can help researchers build larger constructs, pick fewer colonies and drive projects to completion faster.
 
Learning Objectives:
  • Gain knowledge of tools that enable fast and cost-effective gene assemblies
  • Explore low-volume gene assembly and QC methods
  • Learn about DNA fragment solutions for gene and pathway assembly

 

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
SEP 13, 2022 8:00 AM PDT
SEP 13, 2022 8:00 AM PDT
Date: September 13, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Preparedness against pandemic diseases demands rapid-response vaccine technology and ready-to-use analytical methods...
Loading Comments...
Show Resources